HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wan-Long Chuang Selected Research

Chronic Hepatitis C

9/2022Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes.
4/2022Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients.
1/2022Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.
1/2022Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients.
1/2022Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
1/2022Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals.
10/2021Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
10/2021Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
8/2021Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
8/2021Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wan-Long Chuang Research Topics

Disease

119Chronic Hepatitis C
09/2022 - 01/2002
104Infections
08/2022 - 01/2002
58Fibrosis (Cirrhosis)
07/2022 - 03/2002
53Hepatocellular Carcinoma (Hepatoma)
04/2022 - 09/2004
37Chronic Hepatitis B
02/2022 - 02/2006
31Neoplasms (Cancer)
02/2022 - 02/2002
22Hepatitis B
07/2022 - 02/2009
22Hepatitis C
01/2022 - 02/2006
21Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 03/2002
14Viremia
12/2021 - 01/2002
10Hepatitis
07/2022 - 06/2007
10Liver Diseases (Liver Disease)
10/2021 - 01/2007
8Insulin Resistance
05/2015 - 04/2009
6Body Weight (Weight, Body)
07/2022 - 02/2006
6Non-alcoholic Fatty Liver Disease
03/2022 - 03/2016
6Chronic Renal Insufficiency
02/2022 - 07/2020
6Hypertension (High Blood Pressure)
01/2022 - 12/2007
6Fatty Liver
12/2021 - 12/2007
5Virus Diseases (Viral Diseases)
02/2022 - 07/2003
5Coinfection
10/2021 - 10/2004
5Disease Progression
01/2021 - 04/2008
4Diabetes Mellitus
01/2022 - 09/2012
4Chronic Kidney Failure (Chronic Renal Failure)
08/2021 - 01/2016
4HIV Infections (HIV Infection)
07/2020 - 01/2014
3Inflammation (Inflammations)
10/2021 - 07/2011
3Hemorrhage
07/2020 - 11/2002
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2020 - 11/2016
3Nasopharyngitis
01/2020 - 11/2016
3Liver Neoplasms (Liver Cancer)
12/2016 - 07/2013
3Headache (Headaches)
11/2016 - 07/2016
3Type 2 Diabetes Mellitus (MODY)
05/2015 - 02/2008
3End Stage Liver Disease
03/2009 - 12/2006
2Glucose Intolerance
09/2022 - 12/2007
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2021
2Cryoglobulinemia
01/2022 - 11/2018
2Hyperuricemia
03/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

60Ribavirin (Virazole)FDA LinkGeneric
01/2022 - 10/2004
52Antiviral Agents (Antivirals)IBA
09/2022 - 04/2008
50InterferonsIBA
01/2022 - 07/2003
35RNA (Ribonucleic Acid)IBA
01/2022 - 01/2002
19Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2021 - 06/2007
19Interferon-alpha (Interferon Alfa)IBA
04/2021 - 01/2002
16Alanine Transaminase (SGPT)IBA
12/2021 - 01/2002
15DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2002
14Hepatitis B e AntigensIBA
07/2022 - 09/2007
10Glucose (Dextrose)FDA LinkGeneric
09/2022 - 12/2007
9Tenofovir (Viread)FDA Link
07/2022 - 01/2016
9Proteins (Proteins, Gene)FDA Link
03/2022 - 05/2011
9Triglycerides (Triacylglycerol)IBA
01/2021 - 07/2006
8Pharmaceutical PreparationsIBA
02/2022 - 06/2012
8Lamivudine (Epivir)FDA Link
11/2016 - 12/2006
7Biomarkers (Surrogate Marker)IBA
04/2022 - 08/2010
7SofosbuvirIBA
02/2022 - 01/2016
7entecavirFDA Link
02/2022 - 01/2014
7Uric Acid (Urate)IBA
03/2020 - 09/2008
7peginterferon alfa-2a (Pegasys)FDA Link
07/2018 - 02/2009
6sofosbuvir drug combination ledipasvirIBA
08/2022 - 07/2016
6tenofovir alafenamideIBA
07/2022 - 11/2016
6Sorafenib (BAY 43-9006)FDA Link
02/2022 - 02/2017
6daclatasvirIBA
01/2021 - 01/2016
5BilirubinIBA
01/2022 - 10/2019
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 02/2015
5nasIBA
10/2021 - 01/2014
5NucleotidesIBA
01/2021 - 01/2014
5micaIBA
01/2019 - 12/2015
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2022 - 01/2011
4CytokinesIBA
01/2022 - 03/2011
4ColchicineFDA LinkGeneric
07/2021 - 09/2013
4asunaprevirIBA
01/2021 - 11/2016
4NucleosidesIBA
01/2021 - 01/2014
4LipidsIBA
11/2020 - 07/2008
4Peptides (Polypeptides)IBA
05/2017 - 10/2010
4CholesterolIBA
05/2015 - 07/2008
3wisteria lectinIBA
03/2022 - 08/2017
3Carrier Proteins (Binding Protein)IBA
03/2022 - 08/2017
3ChemokinesIBA
01/2022 - 05/2010
3Transaminases (Aminotransferases)IBA
12/2021 - 06/2003
3C-Reactive ProteinIBA
11/2021 - 03/2002
3AlbuminsIBA
04/2021 - 01/2015
3AntigensIBA
04/2021 - 11/2016
3Indicators and Reagents (Reagents)IBA
01/2021 - 03/2002
3ledipasvirIBA
12/2018 - 01/2017
3Fetal Proteins (Fetoprotein)IBA
03/2018 - 03/2015
3InterleukinsIBA
03/2018 - 01/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2017 - 06/2003
3Phospholipases (Phospholipase)IBA
03/2016 - 03/2015
3Surface Antigens (Surface Antigen)IBA
04/2014 - 06/2007
3Interleukin-6 (Interleukin 6)IBA
06/2013 - 10/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2013 - 09/2004
3Epirubicin (Ellence)FDA LinkGeneric
12/2011 - 02/2006
2Ferritins (Ferritin)IBA
09/2022 - 02/2019
2Insulin (Novolin)FDA Link
10/2021 - 05/2015
2Long Noncoding RNAIBA
01/2021 - 05/2020

Therapy/Procedure

92Therapeutics
04/2022 - 01/2002
7Renal Dialysis (Hemodialysis)
08/2021 - 02/2002
5Aftercare (After-Treatment)
03/2020 - 08/2005
5Liver Transplantation
06/2018 - 01/2007
4Drug Therapy (Chemotherapy)
02/2022 - 02/2006
3Palliative Care (Palliative Therapy)
07/2021 - 05/2015
3Duration of Therapy
06/2020 - 09/2007